Mutual Fund Details
NAV
₹540.1261
as on 04 Feb 2025, 11:14 PM
₹5.2390(0.98%)
Last Change
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,67,230
₹1,71,794
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹71,794
Profit (absolute return)
71.79%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
4.51%
In the last 6 months
0.90%
In the last 1 year
17.36%
In the last 3 years
71.79%
In the last 5 years
222.49%
In the last 10 years
313.35%
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
Nippon India Pharma Fund Direct-Growth
as of 31 Dec 2024, 05:30 AM
₹8,914.89 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 month.
0.93%
Expense Ratio
Plan
Growth
Benchmark
BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 month.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Dec 2024
Healthcare
98.14%
₹8,749.07 Cr
Cash Holding
1.85%
₹164.93 Cr
Others
0.01%
₹89.15 Lakh
Companies Holding in this Mutual Fund
as on 31 Dec 2024
Sun Pharmaceutical Industries Ltd.
13.47%
₹1,200.84 Cr
Divi's Laboratories Ltd.
8.39%
₹747.96 Cr
Lupin Ltd.
7.67%
₹683.77 Cr
Cipla Ltd.
6.20%
₹552.72 Cr
Dr. Reddy's Laboratories Ltd.
6.05%
₹539.35 Cr
Others
58.22%
₹5,190.25 Cr
View All
View All
This fund's returns:
19.75%Return Duration
3 Years
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
16.47%
24.38%
3Y Returns
24.38
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
16.47%
24.38%
3Y Returns
24.14
DSP Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
16.47%
24.38%
3Y Returns
22.27
About Nippon India Pharma Fund Direct-Growth
Nippon India Pharma Fund Direct-Growth is a Equity mutual fund scheme from Nippon India Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹8,914.89 Crores and the latest NAV decalared is ₹540.126 as on 05 Feb 2025 at 11:25 am.
Nippon India Pharma Fund Direct-Growth scheme return performance in last 1 year is 17.36%, in last 3 years is 71.79% and 673.10% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹8,914.89 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
Nippon India Mutual Fund
View AMC Details
₹5,60,995.66 Cr
AUM
266
Schemes
Address
4th Floor, Tower A, Peninsula Business Park,Ganapatrao Kadam Marg, Lower Parel (W),400013
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
